The Study
Early microglial response to amyloid plaques drives sleep loss in Alzheimer's disease
This study looked at mice with a brain disease similar to Alzheimer’s and found that when they had sticky plaques, they slept less. When scientists removed certain brain cells, the mice slept more. But this doesn’t prove the cells caused the sleep loss — it just shows they’re linked.
Analysis score
Maximum 72 for a cohort study.
Where the score came from
When mice get amyloid plaques (like in early Alzheimer's), they lose a lot of deep sleep — but not because the plaques keep growing. Instead, immune cells in the brain called microglia get overactive and mess up sleep.
Where does this study sit?
Reviews of RCTs (Meta-analyses)
Max 100Randomized Trials
Max 90Reviews of Cohort Studies
Max 85Cohort Studies
Max 72Reviews of Case-Control Studies
Max 63Case-Control Studies
Max 58Cross-Sectional & Case Series
Max 50Expert Opinion
Max 516 / 100
Quality score
Groups of people are followed over time to see who develops an outcome. Strong for identifying risk factors and associations, but cannot prove causation as firmly as RCTs.
Key takeaways
Summary
Based on the study abstract and findings.
- 1Yes — losing 2 hours of deep sleep daily would severely impact brain cleaning and memory in humans, and this study shows it might be fixable without removing plaques.
- 2Mice with plaques lost 1.5–2 hours of deep sleep per day.
- 3When scientists removed microglia, those mice got back over 2 hours of deep sleep — even though the plaques were still there.
Score breakdown, methodology, conflicts of interest, evidence analysis & raw study data
Publication
Journal
Alzheimer's & Dementia
Year
2026
Authors
Nicholas J. Constantino, Riley E. Irmen, Matthew J. Lanning, Sierra M. Turner, Clair C. Ashley, Caitlin M. Carroll, Evan M. Neary, D. Rubinow, J. A. Snipes, S. Macauley
Related Content
Claims (6)
During sleep, the brain removes waste products through the glymphatic system, and this removal process is involved in the development of neurodegenerative diseases.
In genetically modified mice prone to amyloid plaque formation, the appearance of these plaques is linked to a daily loss of 1.5 to 2 hours of deep sleep, regardless of whether plaques continue to grow.
In mice genetically engineered to develop Alzheimer’s-like brain changes, removing microglia with a specific drug increases daily NREM sleep by more than two hours, even though the amount of amyloid plaques in the brain remains unchanged.
In APPswe/PSEN1dE9 mice, amyloid pathology correlates with increased cortical electrical activity and decreased synchronization of brain waves in theta and delta bands, which correspond to disrupted sleep stability and lower quality non-REM sleep.
In mice, aging decreases REM sleep and eliminates the compensatory increase in sleep after sleep loss, regardless of amyloid buildup, showing that aging and amyloid pathology affect sleep through different biological pathways.
In genetically modified mice modeling Alzheimer’s disease, immune cells in the brain called microglia increase in number in brain regions involved in sleep regulation, even where no amyloid plaques are present, suggesting a widespread response to underlying disease processes.
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.